General Elements of Informed Consent

Informed consent is one of the cornerstones of ethical human subjects research. Before participants agree to take part in a study, they should receive enough information to make an informed decision about whether participation is right for them.

As part of our informed consent series, we’re taking a closer look at the required elements of informed consent and some of the practical considerations that investigators often overlook when preparing consent documents for IRB review.

Whether you’re conducting a social and behavioral study, a clinical investigation, or a minimal risk survey, understanding these informed consent requirements can help streamline the review process and improve the participant experience.

Federal regulations outline several basic elements that must generally be included in informed consent documents. These requirements are intended to ensure that participants understand what participation involves and what rights they have throughout the research process.

The required elements include:

1. A Statement That the Activity Is Research

Participants should clearly understand that they are being invited to participate in research.

The consent form should explain:

  • The purpose of the study,
  • The expected duration of participation,
  • The procedures that will occur, and
  • Which procedures, if any, are considered experimental.

Avoid technical language whenever possible. Participants should be able to understand exactly what they are agreeing to do.

2. A Description of Risks or Discomforts

Researchers must describe any reasonably foreseeable risks associated with participation.

Depending on the study, these risks may include:

  • Emotional discomfort,
  • Social risks,
  • Loss of confidentiality,
  • Physical risks, or
  • Potential inconvenience.

Even studies involving minimal risk should include a discussion of any anticipated discomforts.

3. A Description of Benefits

Consent forms should describe any direct benefits participants may reasonably expect from participation.

If participants are not expected to receive a direct benefit, investigators should say so while noting any potential benefits to society or future research.

4. Alternative Procedures or Treatments

When applicable, participants should be informed of alternatives that may be advantageous to them.

This element most commonly applies to clinical research involving treatments or interventions.

5. Confidentiality Protections

Participants deserve to understand how their information will be handled.

Consent forms should explain:

  • How records will be stored,
  • Who will have access to identifiable information,
  • Whether confidentiality can be guaranteed, and
  • The extent to which records may be reviewed by regulatory authorities.

For research involving more than minimal risk, investigators must explain:

  • Whether compensation is available if injury occurs,
  • Whether medical treatment is available, and
  • How participants can obtain additional information.

7. Contact Information

Participants should know who to contact if they have questions.

This includes contact information for:

  • The research team regarding study-related questions, and
  • The IRB who approved the study regarding participants’ rights.

8. A Statement Regarding Voluntary Participation

Consent forms should clearly state that:

  • Participation is voluntary,
  • Choosing not to participate will not result in penalties or loss of benefits,
  • Participants may withdraw at any time, and
  • Withdrawal may occur without penalty or loss of benefits to which they are otherwise entitled.

9. Future Use of Identifiable Information or Biospecimens

For studies involving identifiable private information or identifiable biospecimens, consent forms must address future use.

Investigators must indicate either that:

  • Identifiers may be removed and the information or biospecimens could be used for future research without obtaining additional consent, or
  • The information and biospecimens will not be used or distributed for future research studies.

Additional Elements Solutions IRB Frequently Looks For

In addition to the regulatory requirements, Solutions IRB often identifies several practical items that help improve clarity and reduce requests for revisions during the review process.

Multiple Research Team Contacts

We recommend providing at least two methods of contact for the Principal Investigator or study team whenever possible.

For example:

  • Telephone number,
  • Email address, or
  • Other appropriate contact information.

This helps ensure participants can reach the research team if questions arise.

Information About Participant Rights

Solutions IRB expects participants to receive information about whom they may contact regarding their rights as research participants.

Language similar to the following is commonly included:

“If you have questions about your rights as a research participant, you may contact Solutions IRB at (855) 226-4472 or participants@solutionsirb.com.”

Solutions IRB’s contact information should generally appear after the study team’s contact information.

Participants should affirmatively indicate their agreement to participate.

Examples include:

  • “By signing below, you consent to participate in this study.”
  • “By clicking ‘Continue,’ you consent to participate in this study.”

The statement should align with the method of obtaining consent.

Audio and Video Recording Disclosures

If interviews, focus groups, or study procedures will be audio or video recorded, the consent form should explain:

  • That recording will occur,
  • Whether participants may decline recording and still participate, and
  • Any separate acknowledgment required for recording.

Withdrawal Instructions

Participants should understand how to withdraw from the study.

Consent forms should address:

  • Who participants should contact,
  • How withdrawal requests can be made, and
  • What will happen to data already collected, when applicable.

Compensation Details

If participants will receive compensation, consider addressing:

  • The type of compensation provided,
  • How compensation will be delivered,
  • When compensation will be issued, and
  • Whether partial compensation is available if participants withdraw early.

Conflict of Interest Disclosures

Any applicable conflicts of interest should be disclosed so participants can make an informed decision regarding participation.

Readability Matters

Consent forms should be written at an appropriate reading level for the intended population.

For studies involving the general adult population, an approximately eighth-grade reading level is often recommended.

Pagination and Document Organization

Finally, don’t overlook the basics. Consent forms should be properly paginated and organized to help participants navigate the information presented.

Final Thoughts

Developing an effective informed consent document involves more than checking regulatory boxes. A well-written consent form promotes transparency, supports participant autonomy, and can help facilitate a smoother IRB review process.

At Solutions IRB, we work with researchers to ensure that informed consent materials meet regulatory requirements while remaining clear and understandable for participants. Taking the time to develop strong consent documents upfront can reduce revisions and help studies move forward more efficiently.

Stay tuned for the rest of our informed consent series, where we’ll explore waiver of documentation of consent, waiver or alteration of consent, broad consent, and other topics researchers frequently encounter during the IRB review process.

Scroll to Top